Clear Creek Bio

Clear Creek Bio is a clinical-stage biotechnology company focused on developing host-targeted and direct-acting small molecule antiviral therapies for SARS-CoV-2 and other viruses. The company’s lead candidate, Brequinar, is currently in a Phase II clinical trial for the treatment of SARS-CoV-2 infection.